Evidence map›Paper›PMID 37689780›Full record

ArticleNPJ Regenerative medicine2023

Opposing roles for TGFβ- and BMP-signaling during nascent alveolar differentiation in the developing human lung.

Tristan Frum, Peggy P Hsu, Renee F C Hein, Ansley S Conchola, Charles J Zhang, Olivia R Utter, Abhinav Anand, Yi Zhang, Sydney G Clark, Ian Glass and 2 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Tristan FrumDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0003-3452-8762
Peggy P HsuDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Renee F C HeinDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Ansley S ConcholaProgram in Cell and Molecular Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Charles J ZhangDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.
Olivia R UtterDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Abhinav AnandDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Yi ZhangDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Sydney G ClarkProgram in Cell and Molecular Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0009-0002-7640-483X
Ian GlassDepartment of Pediatrics, Genetic Medicine, University of Washington, Seattle, WA, 98195, USA.
Jonathan Z SextonDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0002-9244-5888
Jason R SpenceDepartment of Internal Medicine, Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. spencejr@umich.edu.ORCID http://orcid.org/0000-0001-7869-3992
University of Michigan · USUniversity of Washington · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
Supplement to a Hox-Wnt-Sox signaling axis regulates lung development, patterning and branchingR01HL119215 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPENCE, JASON · 2013 to 2021
$4.2M
Functional interrogation of a novel SCGB3A2+/SFTPB+ cell in the human airwayR01HL166139 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason Spence · 2023 to 2026
$2.4M
Small molecules for expansion of islet beta-cell mass in diabetesR01DK120623 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NEWGARD, CHRISTOPHER B, SEXTON, JONATHAN ZACHARY · 2019 to 2021
$2.0M
Characterization of a New Epithelial Cell in the Developing Human LungF30HL156474 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CONCHOLA, ANSLEY CORINNE SEMACK · 2021 to 2023
$137k
Investigating the role of mesenchymal R-Spondin2 during human lung developmentF31HL152531 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CONWAY, RENEE FRANCES · 2020 to 2022
$110k
NCI NIH HHS P30 CA046592NHLBI NIH HHS F30 HL156474NHLBI NIH HHS F31 HL152531NHLBI NIH HHS R01 HL119215NHLBI NIH HHS R01 HL166139NICHD NIH HHS R24 HD000836NIDCR NIH HHS T32 DE007057NIDDK NIH HHS R01 DK120623NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Alveolar type 2 (AT2) cells function as stem cells in the adult lung and aid in repair after injury. The current study aimed to understand the signaling events that control differentiation of this therapeutically relevant cell type during human development. Using lung explant and organoid models, we identified opposing effects of TGFβ- and BMP-signaling, where inhibition of TGFβ- and activation of BMP-signaling in the context of high WNT- and FGF-signaling efficiently differentiated early lung progenitors into AT2-like cells in vitro. AT2-like cells differentiated in this manner exhibit surfactant processing and secretion capabilities, and long-term commitment to a mature AT2 phenotype when expanded in media optimized for primary AT2 culture. Comparing AT2-like cells differentiated with TGFβ-inhibition and BMP-activation to alternative differentiation approaches revealed improved specificity to the AT2 lineage and reduced off-target cell types. These findings reveal opposing roles for TGFβ- and BMP-signaling in AT2 differentiation and provide a new strategy to generate a therapeutically relevant cell type in vitro.

Identifiers

PMID37689780
PMCPMC10492838
OpenAlexW4386574175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.